The article "A new direction or the end of the road" published in Marie Claire September 2010 issue, can be read online on the Australian Consumer Patients' Rights Group website link http://www.acpr.com.au/pdf/marie-claire-article.pdf . It is about individuals who, suffering from depression, became suicidal and/or homicidal when taking antidepressants. A gene test may have prevented these disastrous side effects.
GenesFX launches new interactive pharmacogenomic website at the Australian Pharmacogenomic Summit.
Australian Pharmacogenomics Summit - Set to revolutionise healthcare delivery both in Australia and across the globe, the potential for targeted therapies is huge. "In total worldwide spending on new pharmacogenomic technologies is predicted to be more than $3.7billion in 2009" - Australian Centre for Health Research
GenesFX Health provides a pharmacogenomic testing service using a NATA accredited national pathology provider in Australia.
July 2009
GenesFX publishes on TPMT testing. Sheffield,L.J.; Irving,P.; Gupta,A.; Byron,K.; Macrae,F.A.; Phillimore,H.; Dronavalli,M.; Rose,R.; George,P. hiopurine methyltransferase and thiopurine metabolite testing in patients with inflammatory bowel disease who are taking thiopurine drugs Pharmacogenomics10 1077-1081.2009 www.ncbi.nlm.nih.gov/pubmed/19604082
New England Journal of Medicine (NEJM) - Article showing that the best way to work out warfarin dose is to use pharmacogenomic testing and this is better than using clinical information or a fixed dose. www.ncbi.nlm.nih.gov/pubmed/19228618
January 2009
New England Journal of Medicine. - Article showing that the drug clopidogrel does not work as well in individuals who have abnormal pharmacogenomic test results and they have a greater risk of heart attacks and stroke. www.ncbi.nlm.nih.gov/pubmed/19106083
February 2008
New clinical study investigating "Factors contributing to bleeding risk in patients receiving warfarin" conducted by GenesFX and Monash University